The effect of soy intake on metabolic profiles of women with gestational diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 12, 2015, Pages 4654-4661

  Jamilian, Mehri ^a   Asemi, Zatollah ^b  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL PROTEIN; GLUCOSE; GLUTATHIONE; INSULIN; PROTEIN; SOYBEAN PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VEGETABLE PROTEIN; ANTIOXIDANT; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CHILD HOSPITALIZATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOOD COMPOSITION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; NEONATAL HYPERBILIRUBINEMIA; OXIDATIVE STRESS; PARALLEL DESIGN; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TOTAL ANTIOXIDANT CAPACITY; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS; ANTHROPOMETRY; BLOOD; DIET THERAPY; HOSPITALIZATION; HYPERBILIRUBINEMIA; INCIDENCE; METABOLISM; NEWBORN; POLYHYDRAMNIOS; PREGNANCY; SOY FOOD; STATISTICS AND NUMERICAL DATA;

ADULT; ANTHROPOMETRY; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GLUTATHIONE; HOSPITALIZATION; HUMANS; HYPERBILIRUBINEMIA; INCIDENCE; INFANT, NEWBORN; INSULIN; INSULIN RESISTANCE; POLYHYDRAMNIOS; PREGNANCY; SOY FOODS; TRIGLYCERIDES;

EID: 84951097205     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3454     Document Type: Article

References (47)

1. Benhalima K, Devlieger R, Van Assche A. Screening and management of gestational diabetes. Best Pract Res Clin Obstet Gynaecol. 2015;29:339-349.
2. Viana LV, Gross JL, Azevedo MJ. Dietary intervention in patients with gestational diabetes mellitus: a systematic review and metaanalysis of randomized clinical trials on maternal and newborn outcomes. Diabetes Care. 2014;37:3345-3355.
3. Lowe LP, Metzger BE, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care. 2012;35: 574-580.
4. Gilmartin AB, Ural SH, Repke JT. Gestational diabetes mellitus. Rev Obstet Gynecol. 2008;1:129-134.
5. . Asemi Z, Tabassi Z, Samimi M, Fahiminejad T, Esmaillzadeh A. Favourable effects of the dietary approaches to stop hypertension diet on glucose tolerance and lipid profiles in gestational diabetes: a randomised clinical trial. Br J Nutr. 2013;109:2024-2030.
6. Asemi Z, Samimi M, Tabassi Z, Sabihi SS, Esmaillzadeh A. A randomized controlled clinical trial investigating the effect of DASH diet on insulin resistance, inflammation, and oxidative stress in gestational diabetes. Nutrition. 2013;29:619-624.
7. Asemi Z, SamimiM,Tabassi Z, Esmaillzadeh A. The effect ofDASH diet on pregnancy outcomes in gestational diabetes: a randomized controlled clinical trial. Eur J Clin Nutr. 2014;68:490-495.
8. Bhupathiraju SN, Tucker KL. Greater variety in fruit and vegetable intake is associated with lower inflammation in Puerto Rican adults. Am J Clin Nutr. 2011;93:37-46.
9. Li X, Chen Y, Liu J, et al. Serum metabolic variables associated with impaired glucose tolerance induced by high-fat-high-cholesterol diet in Macaca mulatta. Exp Biol Med (Maywood). 2012;237:1310-1321.
10. Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care. 2008;31:648-654.
11. Chen ST, Ferng SH, Yang CS, Peng SJ, Lee HR, Chen JR. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients. Am J Kidney Dis. 2005;46: 1099-1106.
12. Hermansen K, Hansen B, Jacobsen R, et al. Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects. Eur J Clin Nutr. 2005;59:843-850.
13. Matthan NR, Jalbert SM, Ausman LM, Kuvin JT, Karas RH, Lichtenstein AH. Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr. 2007; 85:960-966.
14. Duranti M, Lovati MR, Dani V, et al. The subunit from soybean 7S globulin lowers plasma lipids and upregulates liver-VLDL receptors in rats fed a hypercholesterolemic diet. J Nutr. 2004;134: 1334-1339.
15. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69: 30-42.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(suppl 1):S81-S90.
17. Gupta P, Narang M, Banerjee BD, Basu S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case control study. BMC Pediatr. 2004;20;4:14.
18. Boulet SL, Alexander GR, Salihu HM, Pass M. Macrosomic births in the united states: determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol. 2003;188:1372-1378.
19. Rautava P, Lehtonen L, Helenius H, Sillanpää M. Effect of newborn hospitalization on family and child behavior: a 12-year follow-up study. Pediatrics. 2003;111:277-283.
20. Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care. 2013;36:845-853.
21. Tatsch E, Bochi GV, Pereira Rda S, et al. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem. 2011;44:348-350.
22. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem. 1996;239:70-76.
23. Beutler E, Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med. 1985;105:581-584.
24. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990;9:515-540.
25. Porter ML, Dennis BL. Hyperbilirubinemia in the term newborn. Am Fam Physician. 2002;65:599-606.
26. Nobile de Santis MS, Radaelli T, Taricco E, Bertini S, Cetin I. Excess of amniotic fluid: pathophysiology, correlated diseases and clinical management. Acta Biomed. 2004;75(suppl 1):53-55.
27. Asemi Z, Karamali M, Esmaillzadeh A. Effects of calcium-vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial. Diabetologia. 2014;57:1798-1806.
28. Wu AH, Stanczyk FZ, Martinez C, et al. A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr. 2005;81:1133-1141.
29. Ho SC, Chen YM, Ho SS, Woo JL. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Menopause. 2007;14:905-912.
30. LiuZM,ChenYM,HoSC,HoYP,WooJ. Effects of soy protein and isoflavones on glycemic control and insulin sensitivity: a 6-mo double- blind, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetes. Am J Clin Nutr. 2010;91:1394-1401.
31. Azadbakht L, KimiagarM,Mehrabi Y, et al. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr. 2007;85: 735-741.
32. Oliva ME, Chicco A, Lombardo YB. Mechanisms underlying the beneficial effect of soy protein in improving the metabolic abnormalities in the liver and skeletal muscle of dyslipemic insulin resistant rats. Eur J Nutr. 2015;54:407-419.
33. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276-282.
34. ZhanS,HoSC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 2005;81:397-408.
35. Zhuo XG, Melby MK, Watanabe S. Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. J Nutr. 2004;134:2395-2400.
36. Miraghajani MS, Esmaillzadeh A, Najafabadi MM, Mirlohi M, Azadbakht L. Soy milk consumption, inflammation, coagulation, and oxidative stress among type 2 diabetic patients with nephropathy. Diabetes Care. 2012;35:1981-1985.
37. Schreihofer DA, Deutsch C, Lovekamp-Swan T, Sullivan JC, Dorrance AM. Effect of high soy diet on the cerebrovasculature and endothelial nitric oxide synthase in the ovariectomized rat. Vascul Pharmacol. 2010;52:236-242.
38. Acharjee S, Zhou JR, Elajami TK, Welty FK. Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status. Metabolism. 2015;64:236-243.
39. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Dietary soya intake alters plasma antioxidant status and lipid peroxidation in postmenopausal women with the metabolic syndrome. Br J Nutr. 2007;98:807-813.
40. Kwak JH, Kim M, Lee E, Lee SH, Ahn CW, Lee JH. Effects of black soy peptide supplementation on blood pressure and oxidative stress: a randomized controlled trial. Hypertens Res. 2013;36:1060-1066.
41. Yang HY, Yang SC, Chen ST, Chen JR. Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with L-NAME-induced hypertension. J Nutr Biochem. 2008;19:833-839.
42. HenemanKM,ChangHC,Prior RL, SteinbergFM.Soy protein with and without isoflavones fails to substantially increase postprandial antioxidant capacity. J Nutr Biochem. 2007;18:46-53.
43. Young IS, McEneny J. Lipoprotein oxidation and atherosclerosis. Biochem Soc Trans. 2001;29:358-362.
44. Kanazawa T, Osanai T, Zhang XS, et al. Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular diseases. J Nutr. 1995;125:639S-646S.
45. Wallner S, Hermetter A, Mayer B, Wascher TC. The-amino group of L-arginine mediates its antioxidant effect. Eur J Clin Invest. 2001; 31:98-102.
46. Zhang H, Zhao D, Shen J, Zhou X, Chen W, Jiang S. Evaluation of oral glucose tolerance test,-cell function and adverse obstetric outcomes. Biomed Rep. 2013;1:807-811.
47. Ferrara A, Weiss NS, Hedderson MM, et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes DataGroupthresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia. 2007;50:298-306.